Part of the reason that Alzheimer's disease is so scary is because there are so few treatments, but there could be one hiding ...

A gene variant called APOE4 is the biggest genetic risk factor for Alzheimer's disease. Scientists are finally figuring out ...

Scientists have uncovered an unexpected culprit behind sleep loss in Alzheimer’s disease: overactive immune cells in the ...

Scientists have found a promising way to protect the brain from Alzheimer’s-related damage by blocking immune cells that ...

Patients with early-onset Alzheimer's disease have a distinct comorbidity profile and increased healthcare use in the years before diagnosis, a study shows.

PRI analysis shows Alzheimer’s biomarkers like Amyloid PET and plasma p-tau217 are driving earlier, precise diagnosis and staging.

Scientists have spent decades trying to get medicine across the blood-brain barrier. Two treatments for a rare genetic ...

Alzheimer's disease may not be a single, uniform condition, but a complex disorder shaped by different combinations of ...

Cell Therapies Pty Ltd and S2N.Bio (“S2N”) have commenced technology transfer of S2N’s cell therapy candidate for Alzheimer’s disease. The transfer will enable GMP manufacture of clinical trial ...

Boosting a protein restored brain rhythms and improved memory in mice with Alzheimer’s-like disease, pointing to a potential ...

A new conceptual framework called the Gut-Brain Homeostatic Continuum reframes Alzheimer's disease as a progressive erosion ...

Walkers, caregivers, families and volunteers gathered Saturday at Razorback Gardens at the University of Arkansas for the Alzheimer’s Association Walk to End Alzheimer’s — Northwest Arkansas.